Amylyx Pharmaceuticals Inc (AMLX) Stock Price

13.285 ▼ -0.595 (-4.29%)
Open: 13.54 Vol: 998.05K Day's range: 13.17 - 13.90 May 15, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
AMLX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 13.26▲ 13.29▼ 13.29▼ 14.21▼ 15.88▼
MA10 13.29▼ 13.31▼ 13.55▼ 14.99▼ 15.21▼
MA20 13.29▼ 13.63▼ 14.02▼ 15.89▼ 14.56▼
MA50 13.28▼ 14.15▼ 14.56▼ 15.36▼ 12.25▲
MA100 13.54▼ 14.67▼ 15.33▼ 14.60▼ 7.97▲
MA200 13.99▼ 15.47▼ 16.25▼ 13.42▼ 14.94▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.006▼ -0.001▼ -0.060▼ -0.371▼ -0.212▼
RSI 48.184▼ 22.325▼ 21.869▼ 30.092▼ 46.986▼
STOCH 17.982▼ 26.500     8.138▼ 7.857▼ 58.183    
WILL %R -50.000     -87.079▼ -92.282▼ -97.380▼ -89.789▼
CCI -115.356▼ -64.585     -85.878     -157.580▼ -70.538    
Latest Filters Detected On AMLX
MA $AMLX Price Crossed Below MA(200) Set Alert
▼ GAP $AMLX Open Gap Down %2 Set Alert
▼ BREAK $AMLX Price Breaks 30 Days Low Set Alert
▼ BREAK $AMLX Price Breaks 20 Days Low Set Alert
▼ BREAK $AMLX Price Breaks 10 Days Low Set Alert
Amylyx Pharmaceuticals Inc News
Amylyx Pharmaceuticals Announces Peer-Reviewed Publication of Phase 2 Open-Label HELIOS Trial Data for AMX0035 in The Journal of Clinical Investigation
Friday, May 15, 2026 08:12 AM
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced that Week 24 and Week 48 results from the Phase 2 open-label HELIOS clinical trial of AMX0035, an oral, ...
Amylyx Pharmaceuticals eyes phase 3 AVEXITIDE readout as 2027 launch comes into focus
Wednesday, May 13, 2026 10:05 PM
3 small-cap biotechs with potential breakthroughs in 2024 Amylyx Pharmaceuticals (NASDAQ:AMLX) is preparing for a pivotal Phase 3 readout for AVEXITIDE, its lead asset for post-bariatric hypoglycemia, ...
Amylyx Pharmaceuticals (AMLX) Price Target Increased by 21.01% to 18.36
Tuesday, October 28, 2025 04:59 PM
The average one-year price target for Amylyx Pharmaceuticals (NasdaqGS:AMLX) has been revised to $18.36 / share. This is an increase of 21.01% from the prior estimate of $15.17 dated September 27, ...
AMLX historical stock data
date open high low close volume
15/05/26 13.54 13.90 13.17 13.285 998,049
14/05/26 14.68 14.71 13.87 13.88 845,933
13/05/26 14.37 14.80 14.24 14.58 1,058,540
12/05/26 14.81 14.83 14.22 14.44 1,084,752
11/05/26 14.84 15.23 14.70 14.88 1,995,366
08/05/26 15.20 15.46 14.51 14.73 1,892,476
07/05/26 15.98 15.98 14.70 15.20 1,452,057
06/05/26 16.51 16.56 15.60 16.06 1,376,766
05/05/26 16.61 16.94 15.98 16.43 1,024,221
04/05/26 15.88 16.46 15.7825 16.46 959,362
Quote Details
52wk Low:4.64
52wk High:18.605
Vol:998.05K
Avg Vol(3m):20.2M
1Y Chng:+159.47%
1M Chng:-16.02%
Add to Watch List
More Information
Index US Composite
Market Cap. 1.47B